Elevated Expression of the Genes for Transforming Growth Factor-β1 and Type VI Collagen in Diffuse Fasciitis Associated with the Eosinophilia-Myalgia Syndrome
- 1 January 1991
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 96 (1) , 20-25
- https://doi.org/10.1111/1523-1747.ep12514683
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Evaluation of Transforming Growth Factor β and Type I Procollagen Gene Expression in Fibrotic Skin Disease by In Situ HybridizationJournal of Investigative Dermatology, 1990
- Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?Journal of Investigative Dermatology, 1990
- Transforming Growth Factor‐βAnnals of the New York Academy of Sciences, 1990
- Collagen gene expression by cultured human skin fibroblasts. Abundant steady-state levels of type VI procollagen messenger RNAs.Journal of Clinical Investigation, 1989
- Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clonesEuropean Journal of Biochemistry, 1987
- Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-βBiochemical and Biophysical Research Communications, 1986
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985
- Immunochemistry, genuine size and tissue localization of collagen VIEuropean Journal of Biochemistry, 1984